scan1

There is a very high incidence of Coronary Artery Disease (CAD) in India associated with high morbidity and mortality and coronary stent implantation is an important treatment. The Central Government has, therefore, included the same in the schedule 1 of the Drugs (Price Control) Order,2013 on 21/12/2016, enabling National Pharmaceuticals  Pricing Authority (NPPA) To Regulate The Prices Of Coronary Stents And Monitor Their Availability . NPPA, after detailed stakeholder consultations, notified the ceiling prices of the coronary stents on 13/02/2017 under two categories:

  1. Bare Metal Stents        – Rs.    7260/-
  2. Drug Eluting metallic DES and including  Stents (DES) AND Bio-resorbable Vascular Scaffold (BVs)/Biodegradable Stents   –      Rs.29,600/

                                           Posted by an order of Hon'ble Vice-Chancellor, University of Allahabad